These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29719240)

  • 41. Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells.
    Abdallah ME; El-Readi MZ; Althubiti MA; Almaimani RA; Ismail AM; Idris S; Refaat B; Almalki WH; Babakr AT; Mukhtar MH; Abdalla AN; Idris OF
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genistein-Chitosan Derivative Nanoparticles for Targeting and Enhancing the Anti-Breast Cancer Effect of Tamoxifen In Vitro.
    Xing Y; Shen W; Sun C; Wang R; Fan B; Liang G
    J Pharm Sci; 2024 Aug; 113(8):2575-2583. PubMed ID: 38801972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.
    Viedma-Rodríguez R; Ruiz Esparza-Garrido R; Baiza-Gutman LA; Velázquez-Flores MÁ; García-Carrancá A; Salamanca-Gómez F; Arenas-Aranda D
    Tumour Biol; 2015 Sep; 36(9):6991-7005. PubMed ID: 25861752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells.
    Wen C; Wu L; Fu L; Zhang X; Zhou H
    Mol Med Rep; 2016 Sep; 14(3):2250-6. PubMed ID: 27432642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase.
    Ismail A; Doghish AS; E M Elsadek B; Salama SA; Mariee AD
    Steroids; 2020 Aug; 160():108656. PubMed ID: 32439410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
    Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
    J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells.
    Xu W; Bae EJ; Lee MK
    Int J Nanomedicine; 2018; 13():7549-7563. PubMed ID: 30532538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
    Loh YN; Hedditch EL; Baker LA; Jary E; Ward RL; Ford CE
    BMC Cancer; 2013 Apr; 13():174. PubMed ID: 23547709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
    Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
    Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance.
    Pitta CA; Papageorgis P; Charalambous C; Constantinou AI
    Cancer Lett; 2013 Sep; 337(2):167-76. PubMed ID: 23752064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells.
    Zhao W; Ma J; Zhang Q; Zhang H; Ma W; Li S; Piao Y; Zhao S; Dai S; Tang D
    Cell Biol Int; 2024 Apr; 48(4):496-509. PubMed ID: 38225685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
    Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
    J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies.
    Sabapati M; Palei NN; C K AK; Molakpogu RB
    Drug Dev Ind Pharm; 2019 Apr; 45(4):577-586. PubMed ID: 30663427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells.
    Zhou Q; Zeng H; Ye P; Shi Y; Guo J; Long X
    Anticancer Drugs; 2018 Jul; 29(6):539-548. PubMed ID: 29557813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity.
    Diaz Bessone MI; Simón-Gracia L; Scodeller P; Ramirez MLA; Lago Huvelle MA; Soler-Illia GJAA; Simian M
    J Nanobiotechnology; 2019 Dec; 17(1):120. PubMed ID: 31812165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
    Ryu CS; Kwak HC; Lee JY; Oh SJ; Phuong NT; Kang KW; Kim SK
    Biochem Pharmacol; 2013 Jan; 85(2):197-206. PubMed ID: 23123664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.
    Wang L; Zhang X; Wang ZY
    Anticancer Res; 2010 Sep; 30(9):3637-42. PubMed ID: 20944147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug.
    Ebrahimi HA; Javadzadeh Y; Hamidi M; Barzegar Jalali M
    J Pharm Pharmacol; 2016 Apr; 68(4):450-8. PubMed ID: 27114047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physico-chemical characterisation, cytotoxic activity, and biocompatibility studies of tamoxifen-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification method.
    Lakkadwala S; Nguyen S; Lawrence J; Nauli SM; Nesamony J
    J Microencapsul; 2014; 31(6):590-9. PubMed ID: 24697190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
    Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
    Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.